Acquisitions was the major growth strategy adopted by the majority players in global Biomaterials market

The biomaterials market is highly fragmented with players such as Royal DSM (Netherlands), Wright Medical Technology, Inc. (U.S.), Corbion N.V. (Netherlands), Zimmer Biomet Holdings, Inc. (U.S.), Bayer AG (Germany), Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Collagen Matrix, Inc. (U.S.).

Acquisitions, Agreements, collaborations, partnerships, & Joint Venture, new product launches and expansion, are major strategies adopted by the players to achieve growth in this market. Acquisitions accounted for 23% of the total strategies adopted by the players in this market. The key players that adopted this strategy include Royal DSM (Netherlands), Wright Medical Technology, Inc. (U.S.), Corbion N.V. (Netherlands), Zimmer Biomet Holdings, Inc. (U.S.), Heraeus Medical Components, Inc. (U.S), Collagen Solutions plc (U.K.), Ceradyne, Inc. (U.S.), Bayer AG (Germany), Purac Biomaterials (Netherlands), Hycail Finland Oy (Finland), DePuy Orthopaedics, Inc. (U.S.), Orthovita, Inc. (U.S.), and Noble Biomaterials, Inc. (U.S.).

Browse PDF Brochure @
 http://www.marketsandmarkets.com/pdfdownload.asp?id=393

Agreements, alliances, partnerships, joint ventures, and collaborations accounted for 19% of the total number of key growth strategies adopted by players in the biomaterials market from 2012 to 2015. Players adopted these strategies to expand their product portfolios and customer base, and fortify their sales channels. The key players that adopted this strategy are Royal DSM (Netherlands), Wright Medical Technology, Inc. (U.S.), Carpenter Technology Corporation (U.S.), Corbion N.V. (Netherlands), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), Heraeus Medical Components, Inc. (U.S), Noble Biomaterials, Inc. (U.S.), and Exactech, Inc. (U.S.)

                                 Image Credit: Google

New product launches accounted for 18% of the total key growth strategies adopted by players in the biomaterials market from 2012 to 2015. Players adopted this strategy to strengthen their existing product portfolios. Key players that adopted this strategy are BASF SE (Germany), Invibio Ltd. (U.K.), Wright Medical Technology, Inc. (U.S.), Evonik Industries AG (Germany), DePuy Orthopaedics, Inc. (U.S.), Biomet, Inc. (U.S.), and Morgan Technical Ceramics (U.K.).

Expansions accounted for 18% of the total number of growth strategies adopted by players in the biomaterials market from 2012 to 2015. Players adopted this strategy to strengthen their networks, increase their global presence, enhance customer experience, and improve relationships with customers. The key players that adopted this strategy are Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Evonik Industries AG (Germany), Heraeus Medical Components, Inc. (U.S), Bayer AG (Germany), Materion Corporation (U.S.), DENTSPLY International Inc. (U.S.), and Morgan Technical Ceramics (U.K.).

Thus, acquisitions were adopted by the majority of players in the biomaterials market to strengthen their product portfolio, combine proprietary technologies in order to create a strong services portfolio and capture the clientele of the acquired company.